The short answer
The EU leans toward precaution: it classifies carcinogens by hazard and can phase out the worst under unified EU-wide laws. The US leans toward risk assessment, spread across agencies like the EPA, OSHA, FDA, and NTP. Each approach has strengths and trade-offs.
The EU uses unified, largely hazard-based frameworks (CLP, REACH, the workplace directive).
The US uses risk-based, agency-specific approaches (EPA, OSHA, FDA, NTP).
The EU can more readily phase out substances based on hazard.
The US often requires risk estimates before acting, which can be slower but more targeted.
Choose how you want to understand this
The full explanation.
Two philosophies, one goal
The European Union and the United States both work to protect people from cancer-causing substances, but they tend to approach the task differently. Understanding the contrast helps make sense of why the same chemical can be handled differently on each side of the Atlantic — and why neither side is simply "right." (This is a comparison of general tendencies; both systems use elements of each approach.)
The EU: precaution and hazard
The EU's frameworks — CLP, REACH, and the workplace directive — lean toward precaution and hazard-based classification:
- A substance is classified largely by its intrinsic hazard (can it cause cancer?).
- That classification can trigger action — SVHC listing, authorisation, restriction — with an emphasis on phasing out the worst substances and pushing toward safer alternatives.
- The rules are unified across the EU, applying the same way in every member state.
Strength: the EU can act on a hazard relatively quickly, without needing a complete real-world risk calculation for every use. Trade-off: it may restrict substances that, at real-world exposure levels, pose little risk.
The US: risk and agencies
The US leans toward risk assessment, spread across multiple agencies, each with its own remit:
- The EPA assesses environmental chemicals (via IRIS) and sets standards for air, water, and cleanup — often estimating how much exposure causes how much risk.
- OSHA sets workplace exposure limits.
- The FDA regulates food, drugs, and cosmetics.
- The NTP publishes the Report on Carcinogens (hazard identification).
There is no single US chemicals law equivalent to REACH. Action often requires estimating real-world risk before restricting a substance.
Strength: decisions can be more targeted to actual risk. Trade-off: the process can be slower and more fragmented, and gaps can appear between agencies.
Why they sometimes disagree
The clearest example is glyphosate. The EU's IARC-influenced, hazard-focused view called it "probably carcinogenic," while the US EPA's risk-based review concluded it is "not likely" carcinogenic at expected exposures. Same chemical, different frameworks, different conclusions — a direct product of the hazard-versus-risk distinction.
California's Proposition 65, interestingly, is a hazard-based system operating within the generally risk-based US — which is part of why it stands out (and draws criticism).
Neither is simply 'better'
It's tempting to crown one system the winner, but they embody a genuine trade-off that reasonable people weigh differently:
- Precaution (EU) protects against uncertain hazards sooner, at the cost of sometimes over-restricting.
- Risk-based precision (US) targets action to real-world risk, at the cost of acting later and less uniformly.
Both aim to protect health. They differ mainly in how they balance caution against precision when the science is uncertain.
The bottom line
The EU regulates carcinogens through unified, precautionary, hazard-based frameworks that can phase out the worst substances; the US relies more on risk-based, agency-specific assessment. Each has real strengths and real trade-offs — and the difference between them is, at heart, another expression of hazard versus risk.
Words to know
Tap any term to see what it means.
Common questions
▸How do the EU and US approaches differ?
The EU leans on precaution and hazard-based classification through unified laws (CLP, REACH, the workplace directive), and can move to phase out the worst substances. The US relies more on risk-based assessment spread across several agencies (EPA, OSHA, FDA, NTP), often requiring risk estimates before acting.
▸Which approach is better?
Neither is simply 'better' — they involve trade-offs. The EU's precaution can act faster on hazards but may restrict substances that pose little real-world risk. The US's risk-based style can be more targeted but slower and more fragmented.
▸Do they ever reach different conclusions?
Yes. Glyphosate is a famous example: hazard-focused and risk-focused assessments led to different regulatory responses. The difference often reflects hazard-versus-risk framing.
▸Is one system hazard-based and the other risk-based?
As a broad generalization, yes — the EU emphasizes hazard and precaution, the US emphasizes risk assessment. But both use elements of each, so the contrast is a matter of emphasis.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Test your knowledge
0 of 4 answered
This quiz checks understanding of educational content only. It is not medical advice. Open this quiz on its own page.